Dallah Healthcare Company SJSC
SAU:4004
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
145.3333
188
|
Price Target |
|
We'll email you a reminder when the closing price reaches SAR.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Dallah Healthcare Company SJSC stock under the Base Case scenario is 114.93 SAR. Compared to the current market price of 162.2 SAR, Dallah Healthcare Company SJSC is Overvalued by 29%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Dallah Healthcare Company SJSC
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Dallah Healthcare Company SJSC cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Dallah Healthcare Company SJSC
Balance Sheet Decomposition
Dallah Healthcare Company SJSC
Current Assets | 1.4B |
Cash & Short-Term Investments | 143m |
Receivables | 830.3m |
Other Current Assets | 428.4m |
Non-Current Assets | 5B |
Long-Term Investments | 1.6B |
PP&E | 3.2B |
Intangibles | 199.4m |
Current Liabilities | 1.2B |
Accounts Payable | 306.8m |
Accrued Liabilities | 184m |
Short-Term Debt | 580.9m |
Other Current Liabilities | 118.6m |
Non-Current Liabilities | 1.9B |
Long-Term Debt | 1.3B |
Other Non-Current Liabilities | 559.5m |
Earnings Waterfall
Dallah Healthcare Company SJSC
Revenue
|
3.1B
SAR
|
Cost of Revenue
|
-1.9B
SAR
|
Gross Profit
|
1.2B
SAR
|
Operating Expenses
|
-612.3m
SAR
|
Operating Income
|
555.6m
SAR
|
Other Expenses
|
-111.9m
SAR
|
Net Income
|
443.7m
SAR
|
Free Cash Flow Analysis
Dallah Healthcare Company SJSC
SAR | |
Free Cash Flow | SAR |
Profitability Score
Profitability Due Diligence
Dallah Healthcare Company SJSC's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
Dallah Healthcare Company SJSC's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Dallah Healthcare Company SJSC's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Score
Dallah Healthcare Company SJSC's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Dallah Healthcare Company SJSC
According to Wall Street analysts, the average 1-year price target for Dallah Healthcare Company SJSC is 172.35 SAR with a low forecast of 141.4 SAR and a high forecast of 201.6 SAR.
Dividends
Current shareholder yield for Dallah Healthcare Company SJSC is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Dallah Healthcare Co. engages in the provision and operation of healthcare programs and utilities. The company is headquartered in Riyadh, Riyadh. The company went IPO on 2012-12-16. The firm operates in the following business segments: Hospitals; Medicines, and Head Office. The Hospitals’ segment objectives are to own, manage, operate and maintain healthcare facilities. The Medicines’ segment objectives are to import, distribute, wholesale and retail medicines, as well as manufacture medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging materials. The Head Office’s segment objectives are to operate, manage and maintain healthcare facilities; wholesale and retail surgical equipment, artificial parts, handicapped and hospitals equipment, as well as other supporting services.
Contact
IPO
Employees
Officers
The intrinsic value of one Dallah Healthcare Company SJSC stock under the Base Case scenario is 114.93 SAR.
Compared to the current market price of 162.2 SAR, Dallah Healthcare Company SJSC is Overvalued by 29%.